Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IUHE.AS(EUR) CXE
ETF Ticker IUHE(EUR) Euronext Amsterdam

Holdings detail for SOLV

Stock Name	Solventum Corp.
Ticker	SOLV(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US83444M1018

Show aggregate SOLV holdings

News associated with SOLV

Wells Fargo & Company Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price: Solventum (NYSE:SOLV – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from $79.00 to $82.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of […] - 2025-09-17 03:06:58
Solventum Completes Sale Of Purification & Filtration Business; Raises Annual Earnings Outlook: (RTTNews) - Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash. - 2025-09-02 10:10:37
Solventum (NYSE:SOLV) Rating Increased to Strong-Buy at Wall Street Zen: Solventum (NYSE:SOLV – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Monday. Several other equities research analysts have also issued reports on SOLV. KeyCorp started coverage on Solventum in a report on Friday, June 6th. They set a […] - 2025-09-01 03:10:44
Solventum (NYSE:SOLV) Stock Rating Lowered by Wall Street Zen: Solventum (NYSE:SOLV – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. A number of other brokerages have also recently commented on SOLV. Morgan Stanley upgraded shares of Solventum from an “equal weight” rating to […] - 2025-08-24 06:14:43
Solventum Corporation (NYSE:SOLV) Shares Sold by Maryland State Retirement & Pension System: Maryland State Retirement & Pension System lessened its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 18.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,479 shares of the company’s stock after selling 1,439 shares during the quarter. Maryland State Retirement […] - 2025-08-15 04:51:01
Solventum Announces Pricing Of Secondary Offering Of 8.80 Mln Common Stock: (RTTNews) - Solventum Corp. (SOLV) announced the pricing of the secondary offering of 8.80 million shares of its common stock, which is expected to result in gross proceeds of about $648 million to 3M Company. All of the shares of common stock are being sold by the Selling Shareh - 2025-08-14 00:33:56
Solventum Corporation (NYSE:SOLV) Shares Purchased by Charles Schwab Investment Management Inc.: Charles Schwab Investment Management Inc. boosted its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,173,960 shares of the company’s stock after buying an additional 24,762 shares during the quarter. Charles Schwab Investment Management […] - 2025-08-13 05:10:47
Blair William & Co. IL Sells 552 Shares of Solventum Corporation (NYSE:SOLV): Blair William & Co. IL lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 4.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,010 shares of the company’s stock after selling 552 shares during the period. Blair William & Co. IL’s holdings in Solventum were worth $837,000 at […] - 2025-08-11 06:24:58
Federated Hermes Inc. Trims Position in Solventum Corporation (NYSE:SOLV): Federated Hermes Inc. trimmed its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 67.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 764 shares of the company’s stock after selling 1,595 shares during the quarter. Federated Hermes Inc.’s holdings in Solventum were worth $58,000 as of its most recent filing with […] - 2025-08-11 05:04:58
Solventum (NYSE:SOLV) Price Target Raised to $94.00: Solventum (NYSE:SOLV – Free Report) had its price objective upped by Piper Sandler from $87.00 to $94.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the company. Morgan Stanley raised Solventum from […] - 2025-08-11 03:08:46
XTX Topco Ltd Grows Stock Position in Solventum Corporation (NYSE:SOLV): XTX Topco Ltd lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 26.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,417 shares of the company’s stock after purchasing an additional 1,356 shares during the quarter. XTX Topco Ltd’s […] - 2025-08-08 04:38:55
Noteworthy Thursday Option Activity: AKAM, EXPE, SOLV: Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Akamai Technologies Inc (Symbol: AKAM), where a total of 8,566 contracts have traded so far, representing approximately 856,600 underlying shares. That amounts to about 5 - 2025-08-07 14:17:28
Financial Analysis: Solventum (NYSE:SOLV) and BG Medicine (OTCMKTS:BGMD): BG Medicine (OTCMKTS:BGMD – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares BG Medicine and […] - 2025-08-05 02:41:00
Solventum Corporation (NYSE:SOLV) Receives $84.38 Average Target Price from Brokerages: Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have earned an average rating of “Hold” from the eleven brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-08-01 02:50:51
Universal Beteiligungs und Servicegesellschaft mbH Buys 584 Shares of Solventum Corporation (NYSE:SOLV): Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 53,143 shares of the company’s stock after purchasing an additional 584 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Solventum were worth $4,041,000 at the […] - 2025-07-29 05:22:58
7,059 Shares in Solventum Corporation (NYSE:SOLV) Purchased by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd acquired a new stake in Solventum Corporation (NYSE:SOLV – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 7,059 shares of the company’s stock, valued at approximately $537,000. Several other institutional investors have also added to or reduced their stakes […] - 2025-07-28 06:02:51
New York State Common Retirement Fund Reduces Holdings in Solventum Corporation (NYSE:SOLV): New York State Common Retirement Fund lowered its position in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 24.1% during the first quarter, Holdings Channel reports. The fund owned 67,549 shares of the company’s stock after selling 21,500 shares during the quarter. New York State Common Retirement Fund’s holdings in Solventum were worth $5,136,000 […] - 2025-07-22 07:09:10
Solventum Corporation (NYSE:SOLV) Shares Sold by Cwm LLC: Cwm LLC cut its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,875 shares of the company’s stock after selling 2,420 shares during the period. Cwm LLC’s holdings in Solventum […] - 2025-07-21 05:18:49
Cerity Partners LLC Buys 1,294 Shares of Solventum Corporation (NYSE:SOLV): Cerity Partners LLC grew its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,466 shares of the company’s stock after buying an additional 1,294 shares during the quarter. Cerity Partners […] - 2025-07-18 04:55:04
Solventum Corporation (NYSE:SOLV) Shares Sold by Arizona State Retirement System: Arizona State Retirement System trimmed its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 0.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,466 shares of the company’s stock after selling 173 shares during the period. Arizona […] - 2025-07-17 05:51:11
Morgan Stanley Upgrades Solventum (NYSE:SOLV) to Overweight: Solventum (NYSE:SOLV – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Tuesday, Marketbeat.com reports. The brokerage presently has a $103.00 target price on the stock, up from their prior target price of $80.00. Morgan Stanley’s price target […] - 2025-07-17 05:00:52
Solventum Corporation (NYSE:SOLV) Shares Sold by Stratos Wealth Partners LTD.: Stratos Wealth Partners LTD. lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 50.6% in the 1st quarter, Holdings Channel reports. The firm owned 4,256 shares of the company’s stock after selling 4,355 shares during the period. Stratos Wealth Partners LTD.’s holdings in Solventum were worth $324,000 at the end of […] - 2025-07-16 04:58:53
Solventum Corporation (NYSE:SOLV) Shares Sold by D.A. Davidson & CO.: D.A. Davidson & CO. lowered its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 11.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,478 shares of the company’s stock after selling 1,002 shares during the period. D.A. Davidson & CO.’s holdings in Solventum were worth […] - 2025-07-11 05:26:54
Solventum Corporation (NYSE:SOLV) Receives $81.50 Average Price Target from Analysts: Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to […] - 2025-07-07 02:06:56
Solventum Corporation (NYSE:SOLV) Position Lessened by Cambridge Investment Research Advisors Inc.: Cambridge Investment Research Advisors Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 4.5% during the 1st quarter, HoldingsChannel reports. The firm owned 18,893 shares of the company’s stock after selling 895 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Solventum were worth $1,437,000 as of its most recent […] - 2025-07-04 04:32:51
Sumitomo Mitsui Trust Group Inc. Sells 586 Shares of Solventum Corporation (NYSE:SOLV): Sumitomo Mitsui Trust Group Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 0.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 319,689 shares of the company’s stock after selling 586 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Solventum were worth $24,309,000 at the end of […] - 2025-07-03 05:35:09
Robeco Institutional Asset Management B.V. Purchases 2,544 Shares of Solventum Corporation (NYSE:SOLV): Robeco Institutional Asset Management B.V. lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 8.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 31,238 shares of the company’s stock after purchasing an additional 2,544 shares during the quarter. Robeco Institutional Asset Management […] - 2025-07-02 06:14:53
Mirae Asset Global Investments Co. Ltd. Decreases Position in Solventum Corporation (NYSE:SOLV): Mirae Asset Global Investments Co. Ltd. cut its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,617 shares of the company’s stock after selling 3,174 shares […] - 2025-07-02 05:35:01
Perigon Wealth Management LLC Acquires 159 Shares of Solventum Corporation (NYSE:SOLV): Perigon Wealth Management LLC raised its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 3.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,352 shares of the company’s stock after acquiring an additional 159 shares during the quarter. Perigon Wealth […] - 2025-07-01 05:09:18
Solventum Corporation (NYSE:SOLV) Shares Purchased by Sequoia Financial Advisors LLC: Sequoia Financial Advisors LLC increased its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 137.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,344 shares of the company’s stock after purchasing an additional 10,027 shares during the quarter. […] - 2025-06-30 06:10:48

iShares S&P 500 Health Care Sector UCITS ETF SOLV holdings

Date	Number of SOLV Shares Held	Base Market Value of SOLV Shares	Local Market Value of SOLV Shares	Change in SOLV Shares Held	Change in SOLV Base Value	Current Price per SOLV Share Held	Previous Price per SOLV Share Held
2025-09-18 (Thursday)	69,481	USD 5,167,302	USD 5,167,302	81	USD 26,844	USD 74.37	USD 74.07
2025-09-17 (Wednesday)	69,400	USD 5,140,458	USD 5,140,458	0	USD -4,164	USD 74.07	USD 74.13
2025-09-16 (Tuesday)	69,400	USD 5,144,622	USD 5,144,622	0	USD 63,848	USD 74.13	USD 73.21
2025-09-15 (Monday)	69,400	USD 5,080,774	USD 5,080,774
2025-09-12 (Friday)	69,400	USD 5,093,266	USD 5,093,266
2025-09-11 (Thursday)	69,185	USD 5,105,161	USD 5,105,161	81	USD 183,574	USD 73.79	USD 71.22
2025-09-10 (Wednesday)	69,104	USD 4,921,587	USD 4,921,587	81	USD -110,190	USD 71.22	USD 72.9
2025-09-09 (Tuesday)	69,023	USD 5,031,777	USD 5,031,777	0	USD -117,339	USD 72.9	USD 74.6

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SOLV by Blackrock for IE00BMBKBZ46

Show aggregate share trades of SOLV

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-18 BUY 81 74.370* 72.76
2025-09-11 BUY 81 73.790* 72.74
2025-09-10 BUY 81 71.220* 72.75
2025-08-20 BUY 162 72.850* 72.76
2025-08-19 BUY 81 72.270* 72.76
2025-08-18 BUY 405 70.760* 72.77
2025-08-15 BUY 4,768 71.420* 72.78
2025-08-14 BUY 462 73.200* 72.78
2025-08-13 BUY 308 74.380* 72.77
2025-07-30 BUY 77 72.980* 72.77
2025-07-17 SELL -77 73.860* 72.72 Profit of 5,599 on sale
2025-07-15 SELL -308 73.680* 72.71 Profit of 22,395 on sale
2025-07-14 SELL -770 74.070* 72.70 Profit of 55,980 on sale
2025-07-09 SELL -77 74.190* 72.66 Profit of 5,595 on sale
2025-07-07 SELL -154 76.240* 72.62 Profit of 11,184 on sale
2025-07-02 BUY 77 78.250* 72.50
2025-06-24 SELL -1,309 74.980* 72.41 Profit of 94,784 on sale
2025-06-23 BUY 77 73.250* 72.40
2025-06-20 BUY 2,327 73.570* 72.40
2025-06-18 SELL -74 72.630* 72.39 Profit of 5,357 on sale
2025-06-17 BUY 888 72.760* 72.39
2025-06-13 SELL -148 73.800* 72.36 Profit of 10,710 on sale
2025-06-11 SELL -74 74.410* 72.33 Profit of 5,353 on sale
2025-06-10 SELL -148 75.550* 72.31 Profit of 10,702 on sale
2025-06-09 SELL -222 74.920* 72.29 Profit of 16,048 on sale
2025-05-21 SELL -74 72.760* 72.20 Profit of 5,342 on sale
2025-05-20 SELL -148 74.700* 72.17 Profit of 10,682 on sale
2025-05-15 SELL -222 72.940* 72.12 Profit of 16,010 on sale
2025-05-14 SELL -222 71.140* 72.13 Profit of 16,012 on sale
2025-05-13 BUY 74 73.520* 72.11
2025-05-09 SELL -74 70.230* 72.11 Profit of 5,336 on sale
2025-05-08 BUY 148 66.630* 72.16
2025-05-01 BUY 148 65.620* 72.45
2025-04-24 SELL -74 67.530* 72.75 Profit of 5,384 on sale
2025-04-23 BUY 222 65.900* 72.82
2025-04-15 SELL -74 65.930* 73.31 Profit of 5,425 on sale
2025-04-10 SELL -144 65.170* 73.54 Profit of 10,590 on sale
2025-04-08 SELL -72 63.010* 73.72 Profit of 5,308 on sale
2025-04-07 SELL -72 65.320* 73.82 Profit of 5,315 on sale
2025-04-04 SELL -144 66.200* 73.91 Profit of 10,644 on sale
2025-04-02 BUY 72 76.620* 73.88
2025-04-01 BUY 648 76.340* 73.85
2025-03-31 SELL -432 76.040* 73.82 Profit of 31,892 on sale
2025-03-28 BUY 72 74.750* 73.81
2025-03-26 SELL -48 74.240* 73.78 Profit of 3,542 on sale
2025-03-21 BUY 504 73.970* 73.76
2025-03-20 BUY 296 74.990* 73.75
2025-03-17 SELL -74 75.150* 73.67 Profit of 5,451 on sale
2025-03-12 SELL -421 74.010* 73.68 Profit of 31,017 on sale
2025-03-07 BUY 75 77.930* 73.51
2025-02-28 SELL -225 79.750* 73.14 Profit of 16,457 on sale
2025-02-25 BUY 750 83.560* 72.60
2025-02-20 BUY 525 74.500* 72.49
2025-02-19 BUY 225 73.980* 72.46
2025-02-18 BUY 150 74.340* 72.43
2025-02-13 BUY 375 74.310* 72.32
2025-02-04 BUY 300 74.610* 72.01
2025-01-31 BUY 75 74.060* 71.93
2025-01-29 BUY 75 74.500* 71.77
2025-01-27 BUY 150 75.140* 71.60
2025-01-24 BUY 75 74.990* 71.50
2025-01-02 SELL -2,683 65.930* 71.61 Profit of 192,118 on sale
2024-12-10 SELL -74 69.720* 71.66 Profit of 5,303 on sale
2024-12-09 SELL -1,924 70.630* 71.69 Profit of 137,941 on sale
2024-12-03 SELL -888 70.770* 71.92 Profit of 63,862 on sale
2024-12-02 SELL -370 71.990* 71.91 Profit of 26,608 on sale
2024-11-29 SELL -74 71.510* 71.93 Profit of 5,323 on sale
2024-11-22 SELL -740 70.810* 71.97 Profit of 53,256 on sale
2024-11-21 SELL -370 69.630* 72.08 Profit of 26,671 on sale
2024-11-20 BUY 592 68.390* 72.28
2024-11-18 SELL -871 67.120* 72.89 Profit of 63,487 on sale
2024-11-11 BUY 648 71.530* 73.13
2024-11-08 SELL -2,304 72.430* 73.18 Profit of 168,597 on sale
2024-11-07 SELL -144 75.070* 73.03 Profit of 10,516 on sale
2024-11-01 SELL -144 72.460* 73.05 Profit of 10,519 on sale
2024-10-31 SELL -296 72.580* 73.11 Profit of 21,641 on sale
2024-10-30 BUY 74 73.570* 73.04
2024-10-29 BUY 444 73.350* 72.99
2024-10-28 SELL -222 73.360* 72.92 Profit of 16,188 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-18	BUY	81	74.370*	72.76
2025-09-11	BUY	81	73.790*	72.74
2025-09-10	BUY	81	71.220*	72.75
2025-08-20	BUY	162	72.850*	72.76
2025-08-19	BUY	81	72.270*	72.76
2025-08-18	BUY	405	70.760*	72.77
2025-08-15	BUY	4,768	71.420*	72.78
2025-08-14	BUY	462	73.200*	72.78
2025-08-13	BUY	308	74.380*	72.77
2025-07-30	BUY	77	72.980*	72.77
2025-07-17	SELL	-77	73.860*	72.72 Profit of 5,599 on sale
2025-07-15	SELL	-308	73.680*	72.71 Profit of 22,395 on sale
2025-07-14	SELL	-770	74.070*	72.70 Profit of 55,980 on sale
2025-07-09	SELL	-77	74.190*	72.66 Profit of 5,595 on sale
2025-07-07	SELL	-154	76.240*	72.62 Profit of 11,184 on sale
2025-07-02	BUY	77	78.250*	72.50
2025-06-24	SELL	-1,309	74.980*	72.41 Profit of 94,784 on sale
2025-06-23	BUY	77	73.250*	72.40
2025-06-20	BUY	2,327	73.570*	72.40
2025-06-18	SELL	-74	72.630*	72.39 Profit of 5,357 on sale
2025-06-17	BUY	888	72.760*	72.39
2025-06-13	SELL	-148	73.800*	72.36 Profit of 10,710 on sale
2025-06-11	SELL	-74	74.410*	72.33 Profit of 5,353 on sale
2025-06-10	SELL	-148	75.550*	72.31 Profit of 10,702 on sale
2025-06-09	SELL	-222	74.920*	72.29 Profit of 16,048 on sale
2025-05-21	SELL	-74	72.760*	72.20 Profit of 5,342 on sale
2025-05-20	SELL	-148	74.700*	72.17 Profit of 10,682 on sale
2025-05-15	SELL	-222	72.940*	72.12 Profit of 16,010 on sale
2025-05-14	SELL	-222	71.140*	72.13 Profit of 16,012 on sale
2025-05-13	BUY	74	73.520*	72.11
2025-05-09	SELL	-74	70.230*	72.11 Profit of 5,336 on sale
2025-05-08	BUY	148	66.630*	72.16
2025-05-01	BUY	148	65.620*	72.45
2025-04-24	SELL	-74	67.530*	72.75 Profit of 5,384 on sale
2025-04-23	BUY	222	65.900*	72.82
2025-04-15	SELL	-74	65.930*	73.31 Profit of 5,425 on sale
2025-04-10	SELL	-144	65.170*	73.54 Profit of 10,590 on sale
2025-04-08	SELL	-72	63.010*	73.72 Profit of 5,308 on sale
2025-04-07	SELL	-72	65.320*	73.82 Profit of 5,315 on sale
2025-04-04	SELL	-144	66.200*	73.91 Profit of 10,644 on sale
2025-04-02	BUY	72	76.620*	73.88
2025-04-01	BUY	648	76.340*	73.85
2025-03-31	SELL	-432	76.040*	73.82 Profit of 31,892 on sale
2025-03-28	BUY	72	74.750*	73.81
2025-03-26	SELL	-48	74.240*	73.78 Profit of 3,542 on sale
2025-03-21	BUY	504	73.970*	73.76
2025-03-20	BUY	296	74.990*	73.75
2025-03-17	SELL	-74	75.150*	73.67 Profit of 5,451 on sale
2025-03-12	SELL	-421	74.010*	73.68 Profit of 31,017 on sale
2025-03-07	BUY	75	77.930*	73.51
2025-02-28	SELL	-225	79.750*	73.14 Profit of 16,457 on sale
2025-02-25	BUY	750	83.560*	72.60
2025-02-20	BUY	525	74.500*	72.49
2025-02-19	BUY	225	73.980*	72.46
2025-02-18	BUY	150	74.340*	72.43
2025-02-13	BUY	375	74.310*	72.32
2025-02-04	BUY	300	74.610*	72.01
2025-01-31	BUY	75	74.060*	71.93
2025-01-29	BUY	75	74.500*	71.77
2025-01-27	BUY	150	75.140*	71.60
2025-01-24	BUY	75	74.990*	71.50
2025-01-02	SELL	-2,683	65.930*	71.61 Profit of 192,118 on sale
2024-12-10	SELL	-74	69.720*	71.66 Profit of 5,303 on sale
2024-12-09	SELL	-1,924	70.630*	71.69 Profit of 137,941 on sale
2024-12-03	SELL	-888	70.770*	71.92 Profit of 63,862 on sale
2024-12-02	SELL	-370	71.990*	71.91 Profit of 26,608 on sale
2024-11-29	SELL	-74	71.510*	71.93 Profit of 5,323 on sale
2024-11-22	SELL	-740	70.810*	71.97 Profit of 53,256 on sale
2024-11-21	SELL	-370	69.630*	72.08 Profit of 26,671 on sale
2024-11-20	BUY	592	68.390*	72.28
2024-11-18	SELL	-871	67.120*	72.89 Profit of 63,487 on sale
2024-11-11	BUY	648	71.530*	73.13
2024-11-08	SELL	-2,304	72.430*	73.18 Profit of 168,597 on sale
2024-11-07	SELL	-144	75.070*	73.03 Profit of 10,516 on sale
2024-11-01	SELL	-144	72.460*	73.05 Profit of 10,519 on sale
2024-10-31	SELL	-296	72.580*	73.11 Profit of 21,641 on sale
2024-10-30	BUY	74	73.570*	73.04
2024-10-29	BUY	444	73.350*	72.99
2024-10-28	SELL	-222	73.360*	72.92 Profit of 16,188 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SOLV

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	179,699	1	247,015	72.7%
2025-09-18	190,930	29	298,088	64.1%
2025-09-17	498,672	3	687,705	72.5%
2025-09-16	228,165	327	380,929	59.9%
2025-09-15	554,899	12	778,874	71.2%
2025-09-12	588,136	32	828,293	71.0%
2025-09-11	246,984	1	766,541	32.2%
2025-09-10	188,827	332	335,564	56.3%
2025-09-09	188,522	332	341,428	55.2%
2025-09-08	365,458	198	631,153	57.9%
2025-09-05	127,611	29	238,250	53.6%
2025-09-04	156,465	248	253,843	61.6%
2025-09-03	159,378	103	300,282	53.1%
2025-09-02	159,609	86	281,262	56.7%
2025-08-29	113,324	29	255,672	44.3%
2025-08-28	190,310	320	342,936	55.5%
2025-08-27	156,025	90	316,146	49.4%
2025-08-26	123,604	121	173,811	71.1%
2025-08-25	156,115	7	260,241	60.0%
2025-08-22	240,180	367	380,079	63.2%
2025-08-21	140,496	278	208,892	67.3%
2025-08-20	154,256	530	300,203	51.4%
2025-08-19	141,008	24	317,431	44.4%
2025-08-18	272,535	0	526,917	51.7%
2025-08-15	397,918	956	744,789	53.4%
2025-08-14	785,818	57	1,905,079	41.2%
2025-08-13	139,646	264	281,312	49.6%
2025-08-12	75,373	138	215,210	35.0%
2025-08-11	132,362	550	245,327	54.0%
2025-08-08	354,273	107	703,522	50.4%
2025-08-07	343,618	45	670,944	51.2%
2025-08-06	174,805	6	282,657	61.8%
2025-08-05	167,826	0	258,802	64.8%
2025-08-04	184,021	466	312,375	58.9%
2025-08-01	157,693	108	263,715	59.8%
2025-07-31	101,758	8	215,510	47.2%
2025-07-30	82,277	230	159,103	51.7%
2025-07-29	54,409	29	136,960	39.7%
2025-07-28	75,608	0	149,499	50.6%
2025-07-25	86,733	0	172,970	50.1%
2025-07-24	80,110	112	147,499	54.3%
2025-07-23	71,970	91	163,991	43.9%
2025-07-22	87,106	348	175,006	49.8%
2025-07-21	68,915	26	139,869	49.3%
2025-07-18	74,959	145	166,555	45.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 Health Care Sector UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IUHE.AS(EUR) CXE
ETF Ticker	IUHE(EUR) Euronext Amsterdam